What does Sino Biopharmaceutical do?

Sino Biopharmaceutical develops, makes and sells prescription medicines in China. Its main area is cancer drugs, including targeted pills and antibody injections. It also sells treatments for liver disease, breathing conditions, pain and surgery, and has more drugs in development.

Healthcare · Biotechnology · 1177.HK

What Sino Biopharmaceutical Does & How It Makes Money (1177.HK)

Updated October 2026 · reflects Sino Biopharmaceutical's latest reported financials

Chinese R&D-driven pharmaceutical group focused on oncology and liver drugs. It earns most of its revenue by selling branded modern Chinese medicines and chemical and biologic drugs to hospitals and patients in China.

Sino Biopharmaceutical's story, moat and numbers — in a 3-minute visual book.

Explore Sino Biopharmaceutical on TacticScale →

How Sino Biopharmaceutical makes money

It earns most of its revenue by selling branded modern Chinese medicines and chemical and biologic drugs to hospitals and patients in China. It also holds long-term investments and runs healthcare and hospital businesses.

What Sino Biopharmaceutical does

Sino Biopharmaceutical is a Hong Kong-headquartered investment holding company that runs an R&D-focused pharmaceutical group in mainland China. Its main segment covers modernised Chinese medicines and chemical medicines. The largest part of its portfolio is oncology: anlotinib (Focus V), the PD-1 antibody penpulimab (Annike), benmelstobart (Andewei), several targeted small molecules, and biosimilars of bevacizumab, rituximab, trastuzumab and pertuzumab. Beyond cancer, it sells liver disease drugs such as Tianqing Ganmei and the entecavir tablet Runzhong, the inhaled budesonide Tianqing Suchang, and surgery and pain products including Zepolas cataplasms and the factor VIII therapy Anqixin. Its pipeline includes Lanifibranor for liver disease, several respiratory candidates, and PL-5, an antimicrobial peptide. It also has long-term investment and hospital businesses. The company was incorporated in 2000.

Products & services

Focus V (anlotinib)
Annike (penpulimab)
Andewei (benmelstobart)
Tianqing Ganmei (magnesium isoglycyrrhizinate)
Runzhong (entecavir)
Tianqing Suchang (budesonide inhalation)

What is Sino Biopharmaceutical worth?

Fair value: not published

A reliable owner-earnings fair value isn't available for this company yet — we'd rather say so than print a number we don't trust.

We show a fair value only when the method is trustworthy. See Sino Biopharmaceutical on TacticScale →

Sector Healthcare Industry Biotechnology HQ Hong Kong Ticker 1177.HK Official site

Related companies

Bio-Thera Solutions (688177.SS) · Sino Biological,Inc (301047.SZ)

Understand Sino Biopharmaceutical in 3 minutes →